Group One Trading’s T2 Biosystems, Inc TTOO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-56
| Closed | -$1.24K | – | 8391 |
|
|
2023
Q3 | $1.24K | Buy |
+56
| New | +$1.46K | ﹤0.01% | 7176 |
|
|
2023
Q1 | – | Sell |
-5
| Closed | -$710 | – | 8143 |
|
|
2022
Q4 | $710 | Buy |
+5
| New | +$1.03K | ﹤0.01% | 6903 |
|
|
2022
Q2 | – | Hold |
0
| – | -$1K | – | 8725 |
|
|
2022
Q1 | – | Hold |
0
| – | – | – | 7906 |
|
|
2021
Q4 | – | Sell |
-3
| Closed | -$10.4K | – | 8059 |
|
|
2021
Q3 | $15K | Sell |
3
-1
| -25% | -$5.03K | ﹤0.01% | 7327 |
|
|
2021
Q2 | $26K | Sell |
4
-5
| -56% | -$32.3K | ﹤0.01% | 7042 |
|
|
2021
Q1 | $73K | Sell |
9
-2
| -18% | -$21.2K | ﹤0.01% | 5938 |
|
|
2020
Q4 | $69K | Sell |
11
-2
| -15% | -$12.2K | ﹤0.01% | 4806 |
|
|
2020
Q3 | $87K | Buy |
13
+4
| +44% | +$29.6K | ﹤0.01% | 4293 |
|
|
2020
Q2 | $56K | Buy |
+9
| New | +$38.2K | ﹤0.01% | 4282 |
|
|
2020
Q1 | – | Sell |
-2
| Closed | -$9K | – | 5872 |
|
|
2019
Q4 | $9K | Hold |
2
| – | – | ﹤0.01% | 4638 |
|
|
2019
Q3 | $19K | Buy |
+2
| New | +$16.1K | ﹤0.01% | 4367 |
|
|
2019
Q2 | – | Hold |
0
| – | -$3K | – | 5501 |
|
|
2019
Q1 | – | Sell |
-6
| Closed | -$102K | – | 4544 |
|
|
2018
Q4 | $97K | Buy |
+6
| New | +$141K | ﹤0.01% | 3180 |
|
|
2018
Q3 | – | Sell |
-4
| Closed | -$132K | – | 4700 |
|
|
2018
Q2 | $140K | Hold |
4
| – | – | ﹤0.01% | 3336 |
|
|
2018
Q1 | $127K | Buy |
+4
| New | +$108K | ﹤0.01% | 3108 |
|
Group One Trading's TTOO Position: Q1 2025 in Review
Group One Trading sold out of T2 Biosystems, Inc (TTOO) in Q1 2025, closing a stake of 289 shares — an estimated $121 sold.
Group One Trading first reported a position in TTOO in Q1 2018 and held it in 23 quarters. The position peaked at $117K in Q3 2023. 2 funds tracked by Wall St. Rank hold TTOO as of Q1 2025.
- Group One Trading reported no remaining T2 Biosystems, Inc position as of Q1 2025 after selling out during the quarter.
- Group One Trading sold 289 T2 Biosystems, Inc shares in Q1 2025, an estimated $121.
- Group One Trading first reported a position in T2 Biosystems, Inc in Q1 2018 and held it in 23 quarters.
- Group One Trading's T2 Biosystems, Inc position peaked at $117K in Q3 2023.
- 2 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q1 2025.
Based on Group One Trading's 13F filing for Q1 2025, filed 14 May 2025.